5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.76▲ | 1.72▲ | 1.72▲ | 1.71▼ | 1.60▲ |
MA10 | 1.73▲ | 1.64▲ | 1.64▲ | 1.69▼ | 1.59▲ |
MA20 | 1.65▲ | 1.59▲ | 1.59▲ | 1.60▲ | 1.74▼ |
MA50 | 1.59▲ | 1.56▲ | 1.57▲ | 1.63▲ | 2.21▼ |
MA100 | 1.62▲ | 1.71▲ | 1.74▲ | 1.77▼ | 2.16▼ |
MA200 | 1.78▼ | 1.84▼ | 1.88▼ | 2.13▼ | 3.50▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.014▲ | 0.024▲ | 0.028▲ | 0.011▲ | 0.022▲ |
RSI | 57.229▲ | 59.395▲ | 58.963▲ | 51.699▲ | 44.207▼ |
STOCH | 75.483 | 75.890 | 75.616 | 64.043 | 35.592 |
WILL %R | -18.056▲ | -16.049▲ | -16.049▲ | -49.301 | -64.550 |
CCI | 67.604 | 107.530▲ | 111.450▲ | -57.439 | -21.511 |
Monday, April 28, 2025 05:00 AM
SAN DIEGO and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies ...
|
Monday, April 28, 2025 05:00 AM
Biotech luminary to mentor C-suite and provide strategic guidance - SAN DIEGO and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the ...
|
Wednesday, April 23, 2025 05:00 PM
SAN DIEGO and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/05/25 | 1.50 | 1.66 | 1.50 | 1.66 | 15,094 |
20/05/25 | 1.77 | 1.77 | 1.56 | 1.56 | 37,237 |
19/05/25 | 1.76 | 1.8387 | 1.76 | 1.77 | 4,895 |
16/05/25 | 1.75 | 1.785 | 1.75 | 1.77 | 5,030 |
15/05/25 | 1.72 | 1.82 | 1.72 | 1.77 | 10,199 |
14/05/25 | 1.77 | 1.8203 | 1.7334 | 1.7354 | 10,020 |
13/05/25 | 1.68 | 1.80 | 1.68 | 1.72 | 9,716 |
12/05/25 | 1.73 | 1.8399 | 1.5934 | 1.70 | 55,639 |
09/05/25 | 1.70 | 1.7241 | 1.60 | 1.60 | 7,252 |
08/05/25 | 1.54 | 1.60 | 1.475 | 1.60 | 7,392 |
|
|
||||
|
|
||||
|
|